Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
MONOPHARMA

Mono Pharmacare Share Price

 

 

Mono Pharmacare live price: ₹12.5. It opened at ₹13 vs previous close ₹13; intraday high/low: ₹13/₹13. The 50 & 200 DMA stand at ₹13.02/₹20.50.

Mono Pharmacare Performance

  • Today's Low
  • ₹13
  • Today's High
  • ₹13
  • 52 Week Low
  • ₹9
  • 52 Week High
  • ₹28
  • Open Price₹13
  • Previous Close₹13
  • Volume6,000
  • 50 DMA₹13.02
  • 100 DMA₹15.59
  • 200 DMA₹20.50

Mono Pharmacare Chart

Investment Returns

  • Over 1 Month + 2.46%
  • Over 3 Month 0%
  • Over 6 Month -40.48%
  • Over 1 Year -48.67%

Smart Investing Starts Here Start SIP with Mono Pharmacare for Steady Growth!

Invest Now

Mono Pharmacare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 7.1
  • PEG Ratio
  • -
  • Market Cap Cr
  • 22
  • P/B Ratio
  • 0.7
  • Average True Range
  • 0.59
  • EPS
  • 1.75
  • Dividend Yield
  • 0
  • MACD Signal
  • 0
  • RSI
  • 51.94
  • MFI
  • 40.14

Mono Pharmacare Financials

Mono Pharmacare Technicals

EMA & SMA

Current Price
₹12.50
-0.6 (-4.58%)
pointer
  • Bearish Moving Average 9
  • Bullish Moving Average 7
  • 20 Day
  • ₹12.27
  • 50 Day
  • ₹13.02
  • 100 Day
  • ₹15.59
  • 200 Day
  • ₹20.50

Resistance and Support

12.5 Pivot Speed
  • R3 12.50
  • R2 12.50
  • R1 12.50
  • S1 12.50
  • S2 12.50
  • S3 12.50

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Mono Pharmacare Ltd has an operating revenue of Rs. 356.98 Cr. on a trailing 12-month basis. An annual revenue growth of 38% is outstanding, Pre-tax margin of 3% needs improvement, ROE of 9% is fair but needs improvement. The company has a debt to equity of 83%, which is bit higher. From an O'Neil Methodology perspective, the stock has an EPS Rank of 40 which is a POOR score indicating inconsistency in earnings, a RS Rating of 9 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 133 indicates it belongs to a poor industry group of Medical-Whlsle Drg/Suppl and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Mono Pharmacare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-03-30 Others To consider other business matters
2025-11-29 Quarterly Results & Others To consider other business matters (Revised)
2025-08-26 Others To consider other business matters
2025-05-30 Audited Results & Others (Revised) To consider other business matters.
2025-04-11 Others To consider other business matters (Revised)

Mono Pharmacare F&O

Mono Pharmacare Shareholding Pattern

56.72%
34.47%
8.81%

Mono Pharmacare FAQs

Mono Pharmacare share price is ₹12 As on 21 April, 2026 | 21:56

The Market Cap of Mono Pharmacare is ₹22.1 Cr As on 21 April, 2026 | 21:56

The P/E ratio of Mono Pharmacare is 7.1 As on 21 April, 2026 | 21:56

The PB ratio of Mono Pharmacare is 0.7 As on 21 April, 2026 | 21:56

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23